Letter from the Editor-in-Chief: Neurotherapeutics' Transition to Gold Open Access
Neurotherapeutics
.
2023 Oct;20(6):1427.
doi: 10.1007/s13311-023-01439-4.
Author
M Maral Mouradian
1
Affiliation
1
RWJMS Institute for Neurological Therapeutics and Department of Neurology, Rutgers Robert Wood Johnson Medical School, Piscataway, NJ, USA. m.mouradian@rutgers.edu.
PMID:
37751077
PMCID:
PMC10684434
(available on
2024-10-01
)
DOI:
10.1007/s13311-023-01439-4
No abstract available
Publication types
Editorial